The effectiveness of cytocardioprotection of patients with the moderately expressed post infarct dysfunction of left heart ventricle: the results of the randomization research of trimetazidine and athenolole

With the purpose of research of clinical efficiency of trimetazidine and atenolol and their influence on morfofunctional parameteres of left ventricle 36 men who have transferred a myocardial infarction are inspected. Patients were randomly divided into 2 groups. Clinical status and function state o...

Full description

Bibliographic Details
Main Authors: V. V. Kalyuzhin, M. A. Solovtsov, D. U. Kamaev
Format: Article
Language:English
Published: Siberian State Medical University (Tomsk) 2002-03-01
Series:Бюллетень сибирской медицины
Subjects:
Online Access:https://bulletin.ssmu.ru/jour/article/view/3849
_version_ 1797873387461148672
author V. V. Kalyuzhin
M. A. Solovtsov
D. U. Kamaev
author_facet V. V. Kalyuzhin
M. A. Solovtsov
D. U. Kamaev
author_sort V. V. Kalyuzhin
collection DOAJ
description With the purpose of research of clinical efficiency of trimetazidine and atenolol and their influence on morfofunctional parameteres of left ventricle 36 men who have transferred a myocardial infarction are inspected. Patients were randomly divided into 2 groups. Clinical status and function state of left ventricle (by echocardiography) was assessed before and after 4-week therapy with trimetazidine or atenolol. Atenolol and trimetazidine have shown in our study identical clinical efficiency. However while atenolol is statistically significant reduced systolic arterial pressure and heart rate, thickness of posterior wall of left ventricle and corrects diastolic function, trimetazidine had no such activity. Treatment with trimetazidine promoted improvement of local contractility of left ventricle.
first_indexed 2024-04-10T01:15:23Z
format Article
id doaj.art-8820cda35b1c44a4b65c1be6b456e900
institution Directory Open Access Journal
issn 1682-0363
1819-3684
language English
last_indexed 2024-04-10T01:15:23Z
publishDate 2002-03-01
publisher Siberian State Medical University (Tomsk)
record_format Article
series Бюллетень сибирской медицины
spelling doaj.art-8820cda35b1c44a4b65c1be6b456e9002023-03-13T09:58:00ZengSiberian State Medical University (Tomsk)Бюллетень сибирской медицины1682-03631819-36842002-03-0111404410.20538/1682-0363-2002-1-40-442456The effectiveness of cytocardioprotection of patients with the moderately expressed post infarct dysfunction of left heart ventricle: the results of the randomization research of trimetazidine and athenololeV. V. Kalyuzhin0M. A. Solovtsov1D. U. Kamaev2Сибирский государственный медицинский университетСибирский государственный медицинский университетСибирский государственный медицинский университетWith the purpose of research of clinical efficiency of trimetazidine and atenolol and their influence on morfofunctional parameteres of left ventricle 36 men who have transferred a myocardial infarction are inspected. Patients were randomly divided into 2 groups. Clinical status and function state of left ventricle (by echocardiography) was assessed before and after 4-week therapy with trimetazidine or atenolol. Atenolol and trimetazidine have shown in our study identical clinical efficiency. However while atenolol is statistically significant reduced systolic arterial pressure and heart rate, thickness of posterior wall of left ventricle and corrects diastolic function, trimetazidine had no such activity. Treatment with trimetazidine promoted improvement of local contractility of left ventricle.https://bulletin.ssmu.ru/jour/article/view/3849ишемическая дисфункция миокардалечениетриметазидинатенолол
spellingShingle V. V. Kalyuzhin
M. A. Solovtsov
D. U. Kamaev
The effectiveness of cytocardioprotection of patients with the moderately expressed post infarct dysfunction of left heart ventricle: the results of the randomization research of trimetazidine and athenolole
Бюллетень сибирской медицины
ишемическая дисфункция миокарда
лечение
триметазидин
атенолол
title The effectiveness of cytocardioprotection of patients with the moderately expressed post infarct dysfunction of left heart ventricle: the results of the randomization research of trimetazidine and athenolole
title_full The effectiveness of cytocardioprotection of patients with the moderately expressed post infarct dysfunction of left heart ventricle: the results of the randomization research of trimetazidine and athenolole
title_fullStr The effectiveness of cytocardioprotection of patients with the moderately expressed post infarct dysfunction of left heart ventricle: the results of the randomization research of trimetazidine and athenolole
title_full_unstemmed The effectiveness of cytocardioprotection of patients with the moderately expressed post infarct dysfunction of left heart ventricle: the results of the randomization research of trimetazidine and athenolole
title_short The effectiveness of cytocardioprotection of patients with the moderately expressed post infarct dysfunction of left heart ventricle: the results of the randomization research of trimetazidine and athenolole
title_sort effectiveness of cytocardioprotection of patients with the moderately expressed post infarct dysfunction of left heart ventricle the results of the randomization research of trimetazidine and athenolole
topic ишемическая дисфункция миокарда
лечение
триметазидин
атенолол
url https://bulletin.ssmu.ru/jour/article/view/3849
work_keys_str_mv AT vvkalyuzhin theeffectivenessofcytocardioprotectionofpatientswiththemoderatelyexpressedpostinfarctdysfunctionofleftheartventricletheresultsoftherandomizationresearchoftrimetazidineandathenolole
AT masolovtsov theeffectivenessofcytocardioprotectionofpatientswiththemoderatelyexpressedpostinfarctdysfunctionofleftheartventricletheresultsoftherandomizationresearchoftrimetazidineandathenolole
AT dukamaev theeffectivenessofcytocardioprotectionofpatientswiththemoderatelyexpressedpostinfarctdysfunctionofleftheartventricletheresultsoftherandomizationresearchoftrimetazidineandathenolole
AT vvkalyuzhin effectivenessofcytocardioprotectionofpatientswiththemoderatelyexpressedpostinfarctdysfunctionofleftheartventricletheresultsoftherandomizationresearchoftrimetazidineandathenolole
AT masolovtsov effectivenessofcytocardioprotectionofpatientswiththemoderatelyexpressedpostinfarctdysfunctionofleftheartventricletheresultsoftherandomizationresearchoftrimetazidineandathenolole
AT dukamaev effectivenessofcytocardioprotectionofpatientswiththemoderatelyexpressedpostinfarctdysfunctionofleftheartventricletheresultsoftherandomizationresearchoftrimetazidineandathenolole